These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32858440)

  • 1. Identification of integrative molecular and clinical profiles of Fibrinogen-like protein 2 in gliomas using 1323 samples.
    Song Z; Wang Y; Du Y; Zhang Z; Yuan Y
    Int Immunopharmacol; 2020 Nov; 88():106894. PubMed ID: 32858440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
    Yan J; Kong LY; Hu J; Gabrusiewicz K; Dibra D; Xia X; Heimberger AB; Li S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
    Latha K; Yan J; Yang Y; Gressot LV; Kong LY; Manyam G; Ezhilarasan R; Wang Q; Sulman EP; Eric Davis R; Huang S; Fuller GN; Rao A; Heimberger AB; Li S; Rao G
    J Natl Cancer Inst; 2019 Mar; 111(3):292-300. PubMed ID: 29947810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
    Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
    J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of SIGLEC7 may promote M2-type macrophage polarization leading to adverse prognosis in glioma patients.
    An W; Ren C; Yuan L; Qiu Z; Wang P; Cheng Y; He Z; Han X; Li S; An Y
    Front Immunol; 2024; 15():1411072. PubMed ID: 39211050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma.
    Liu F; Huang J; He F; Ma X; Fan F; Meng M; Zhuo Y; Zhang L
    Sci Rep; 2020 Jul; 10(1):10768. PubMed ID: 32612110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas.
    Guan X; Zhang C; Zhao J; Sun G; Song Q; Jia W
    EBioMedicine; 2018 Sep; 35():233-243. PubMed ID: 30131308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas.
    Yang P; Wang K; Zhang C; Wang Z; Liu Q; Wang J; Jiang T; Shan X
    Cancer Immunol Immunother; 2021 Sep; 70(9):2589-2600. PubMed ID: 33576871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDIA3 correlates with clinical malignant features and immune signature in human gliomas.
    Zhang H; Zhou Y; Cheng Q; Dai Z; Wang Z; Liu F; Fan F; Cui B; Cao H
    Aging (Albany NY); 2020 Aug; 12(15):15392-15413. PubMed ID: 32687065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular immune characterization of ERBB2 in glioma.
    Mei J; Wang T; Xu R; Chen D; Zhang Y
    Int Immunopharmacol; 2021 May; 94():107499. PubMed ID: 33640859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas.
    Zhang H; He J; Dai Z; Wang Z; Liang X; He F; Xia Z; Feng S; Cao H; Zhang L; Cheng Q
    Front Immunol; 2021; 12():628966. PubMed ID: 33664747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.
    Wang ZL; Wang Z; Li GZ; Wang QW; Bao ZS; Zhang CB; Jiang T
    Front Immunol; 2019; 10():1756. PubMed ID: 31428092
    [No Abstract]   [Full Text] [Related]  

  • 13. Glioma hexokinase 3 positively correlates with malignancy and macrophage infiltration.
    Liang T; Zhou X; Wang Y; Ma W
    Metab Brain Dis; 2024 Jun; 39(5):719-729. PubMed ID: 38687460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.
    Wang ZL; Li GZ; Wang QW; Bao ZS; Wang Z; Zhang CB; Jiang T
    Oncoimmunology; 2019; 8(2):e1541535. PubMed ID: 30713802
    [No Abstract]   [Full Text] [Related]  

  • 15. An immune-related lncRNA signature for patients with anaplastic gliomas.
    Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
    J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer.
    Feng Y; Guo C; Wang H; Zhao L; Wang W; Wang T; Feng Y; Yuan K; Huang G
    Med Sci Monit; 2020 Jul; 26():e923531. PubMed ID: 32716910
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Gao X; Liu Y; Hong S; Yang H; Guan B; Ma X
    J Integr Neurosci; 2023 Aug; 22(5):135. PubMed ID: 37735118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
    Zhang C; Li J; Wang H; Song SW
    Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging-based radiomic features for extrapolating infiltration levels of immune cells in lower-grade gliomas.
    Zhang X; Liu S; Zhao X; Shi X; Li J; Guo J; Niedermann G; Luo R; Zhang X
    Strahlenther Onkol; 2020 Oct; 196(10):913-921. PubMed ID: 32025804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome profile and clinical characterization of ICOS expression in gliomas.
    Wang J; Shi F; Shan A
    Front Oncol; 2022; 12():946967. PubMed ID: 36276141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.